Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof
A coated medical balloon that includes a polymeric material having a surface with a therapeutic agent-containing mixture coated thereon, wherein the mixture includes a therapeutic agent, an unsaturated carboxylic acid, and a salt of the unsaturated carboxylic acid.
1. A coated medical balloon comprising a polymeric material having a surface with a therapeutic agent-containing mixture coated thereon, wherein the mixture comprises a therapeutic agent, an unsaturated carboxylic acid, an alkali metal salt of the unsaturated carboxylic acid, and an optional excipient; and further wherein the unsaturated carboxylic acid is selected from the group of fatty acids having a (C6-C20) carbon chain with a single cis C═C bond.
2. The balloon of claim 1 wherein the unsaturated carboxylic acid is oleic acid.
3. The balloon of claim 1 wherein the alkali metal salt is a sodium salt.
4. The balloon of claim 1 wherein the ratio of acid to salt is within a range of 80:20 to 20:80.
5. The balloon of claim 4 wherein the ratio of acid to salt is within a range of 60:40 to 40:60.
6. The balloon of claim 1 wherein the therapeutic agent is a Taxane.
7. The balloon of claim 6 wherein the Taxane is paclitaxel.
8. The balloon of claim 1 wherein the therapeutic agent-containing mixture further comprises an excipient.
9. The balloon of claim 8 wherein the excipient is selected from ascorbic acid, urea, polyethylene glycol, and a triglyceride.
10. A coated medical balloon comprising a surface having a therapeutic agent-containing mixture coated thereon, wherein the mixture comprises a therapeutic agent, an unsaturated carboxylic acid, a salt of the unsaturated carboxylic acid, and an optional excipient, wherein the ratio of acid to salt is within a range of 60:40 to 40:60.
11. A coated medical balloon comprising a surface having a therapeutic agent-containing mixture coated thereon, wherein the mixture comprises a therapeutic agent, an unsaturated carboxylic acid, a salt of the unsaturated carboxylic acid, and an optional excipient, wherein the ratio of acid to salt is within a range of 60:40 to 40:60; and further wherein the unsaturated carboxylic acid is selected from the group of fatty acids having a (C6-C20) carbon chain with a single cis C═C bond.
12. The balloon of claim 11 wherein the unsaturated carboxylic acid is oleic acid.
13. The balloon of claim 11 wherein the salt is an alkali metal salt.
14. The balloon of claim 13 wherein the alkali metal salt is a sodium salt.
15. The balloon of claim 11 wherein the therapeutic agent is a Taxane.
16. The balloon of claim 15 wherein the Taxane is paclitaxel.
17. The balloon of claim 11 wherein the therapeutic agent-containing mixture further comprises an excipient.
18. The balloon of claim 17 wherein the excipient is selected from ascorbic acid, urea, polyethylene glycol, and a triglyceride.
19. A balloon catheter comprising:
an elongated catheter shaft having proximal and distal ends, wherein the catheter shaft defines a longitudinal axis extending between the proximal and distal ends; and
an inflatable balloon located close to the distal end of the catheter shaft, wherein the balloon comprises a polymeric material having a surface with a therapeutic agent-containing mixture coated thereon, wherein the mixture comprises a therapeutic agent, an unsaturated carboxylic acid, an alkali metal salt of the unsaturated carboxylic acid, and an optional excipient; and further wherein the unsaturated carboxylic acid is selected from the group of fatty acids having a (C6-C20) carbon chain with a single cis C═C bond.
20. A balloon catheter comprising:
an elongated catheter shaft having proximal and distal ends, wherein the catheter shaft defines a longitudinal axis extending between the proximal and distal ends; and
an inflatable balloon located close to the distal end of the catheter shaft, wherein the balloon comprises a polymeric material having a surface with a therapeutic agent-containing mixture coated thereon, wherein the mixture comprises a therapeutic agent, an unsaturated carboxylic acid, a salt of the unsaturated carboxylic acid, and an optional excipient, wherein the ratio of acid to salt is within a range of 60:40 to 40:60; and further wherein the unsaturated carboxylic acid is selected from the group of fatty acids having a (C6-C20) carbon chain with a single cis C═C bond.
21. A method of delivering a therapeutic agent to a diseased vessel, the method comprising:
providing a balloon catheter of claim 19 ;
advancing the balloon catheter into the diseased vessel; and
inflating the inflatable balloon to form an inflated balloon that contacts the wall of the diseased vessel and thereby delivers the therapeutic agent from the surface of the inflated balloon to the diseased vessel.
22. A method of delivering a therapeutic agent to a diseased vessel, the method comprising:
providing a balloon catheter of claim 20 ;
advancing the balloon catheter into the diseased vessel; and
inflating the inflatable balloon to form an inflated balloon that contacts the wall of the diseased vessel and thereby delivers the therapeutic agent from the surface of the inflated balloon to the diseased vessel.
23. A method of reducing the amount of therapeutic agent on a coated balloon, the method comprising:
providing a medical balloon comprising a polymeric material having a surface;
combining components comprising a therapeutic agent, an unsaturated carboxylic acid, a salt of the unsaturated carboxylic acid, and an optional excipient to form a mixture; wherein the unsaturated carboxylic acid is selected from the group of fatty acids having a (C6-C20) carbon chain with a single cis C═C bond; and
coating the mixture onto the surface of the medical balloon.
24. A method of reducing the amount of therapeutic agent on a coated balloon, the method comprising:
providing a medical balloon having a surface;
combining components comprising a therapeutic agent, an oleic acid, an alkali metal salt of the oleic acid, and an optional excipient to form a mixture, wherein the ratio of acid to salt is within a range of 80:20 to 20:80; and further wherein the unsaturated carboxylic acid is selected from the group of fatty acids having a (C6-C20) carbon chain with a single cis C═C bond; and
coating the mixture onto the surface of the medical balloon.